CVS Caremark ( CVS) numbers raised at UBS. Shares of CVS now seen reaching $48, according to UBS. Estimates also increased on deeper drive on generic pipeline. Buy rating. Chevron ( CVX) target raised at Oppenheimer to $130. Higher than expected crude oil prices. Outperform rating. Express Scripts ( ESRX) estimates, target raised at UBS. Shares of ESRX now seen reaching $66, according to UBS. Estimates also increased on Medco merger. Buy rating. Infosys Technologies ( INFY) numbers lowered at BMO Capital Markets. Shares of INFY now seen reaching $46. Estimates also lowered on disappointing guidance. Perform rating. JDA Software ( JDAS) numbers cut at Benchmark. Shares of JDAS now seen reaching $38, according to Benchmark. Estimates also reduced, to match the company's new guidance. Overweight rating. Noble ( NE) estimates, target reduced at Guggenheim. NE estimates were cut through 2013, Guggenheim said. New fleet status report shows increased downtime. Buy rating and new $41 price target. Penske Automotive ( PAG) numbers raised at Goldman. Shares of PAG now seen reaching $23, according to Goldman Sachs. Estimates also increased, as the recent UK acquisition should add to earnings. Neutral rating. Tractor Supply ( TSCO) numbers increased at Goldman. TSCO estimates were raised through 2013, Goldman Sachs said. Management boosted guidance. Neutral rating and new $82 price target. Watson Pharmaceuticals ( WPI) numbers lowered at Goldman. Shares of WPI now seen reaching $78, according to Goldman Sachs. Company is facing increased competition. Buy rating and new $78 price target. Wolverine World Wide ( WW) numbers cut at Credit Suisse. WWW estimates were lowered through 2013, Credit Suisse said. as sales could be hurt by unseasonably warm weather this winter. Outperform rating. Wynn Resorts ( WYNN) target lowered at Citigroup to $118, according to Citigroup. Company has still not received formal approval for land in Cotai. Neutral rating. >To submit a news tip, email: email@example.com.